Roche step is positive signal on Herceptin
10th Dec 2005, 00:02 GMT
The Swiss drug maker Roche is donating £1.5 million to the British government to help screen women for breast cancer, a sign that Roche and British health authorities expect wider approval for a promising but expensive drug called Herceptin.
Roche step is positive signal on Herceptin related news:
- Interim Analysis of Phase III Study Shows TAXOTERE Based Regimens With HERCEPTIN Significantly Improved Disease Free Survival in Women With Early-Stage HER2-Positive Breast Cancer — Mammography News from StratCenter.com
- SABCS: Herceptin-Anthracycline Cardiotoxicity Called Real and Persistent — MedPage Today Hematology/Oncology
- Combining herceptin with chemotherapy improves survival in breast cancer — KeralaNext: Health
- Herceptin Plus Chemotherapy Improves Disease-free Survival In Early Breast Cancer — ScienceDaily Headlines: Health & Medicine
- Ambrx, Roche In Technology Deal — socalTECH.com - Southern California High Tech News
- Herceptin proving to be a wonder drug — The Cardio Blog
- Erhaltungstherapie mit MabThera verbessert die Überlebenschancen von Lymphom-Patienten enorm — Presseportal.de Wirtschaft
- Roche update on Tamiflu global supply to meet future world demands — from partnerships to regional sub-licenses — WebWire - Recent Headlines
- Herceptin OK as upfront cancer drug — United Press International - Health Business
- iRock! Wi-Fi Sentry — Gizmodo
Latest news from IHT.com: Business:
- IBM plans to join bid for Guangdong bank
- Deutsche Telekom readies for change of guard
- Venture firms bank on Pelosi to relax Sarbanes-Oxley rules
- U.S. pushes China on surplus
- Sun offers its Java free on Internet
- U.S. radio company may sell for $18 billion
- Slower rise in cost of food helps ease inflation in China
- Hitachi-GE alliance set to expand nuclear work
- Banking matters: Women and profit
- KB Home ousts chief for stock option deal